Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
Abu-Much A, Grines CL, Chen S, Batchelor WB, Zhao D, Falah B, Maini AS, Redfors B, Bellumkonda L, Bharadwaj AS, Moses JW, Truesdell AG, Zhang Y, Zhou Z, Baron SJ, Lansky AJ, Basir MB, O'Neill WW, Cohen DJ. Abu-Much A, et al. Int J Cardiol. 2024 Dec 15;417:132555. doi: 10.1016/j.ijcard.2024.132555. Epub 2024 Sep 11. Int J Cardiol. 2024. PMID: 39270940 Free article. Clinical Trial.
Novel risk score for patients undergoing Impella-assisted high-risk percutaneous coronary intervention.
Lemor A, Shah T, Thompson JB, Protty MB, Mamas MA, Kinnaird T, Bharadwaj AS, Truesdell AG, Schonning MJ, Zhang Y, Hussain Y, Falah B, Cohen DJ, Redfors B, Baron SJ, Witzke CF, Dixon SR, Basir MB, Lansky AJ, O'Neill WW. Lemor A, et al. Cardiovasc Revasc Med. 2025 Dec;81:86-94. doi: 10.1016/j.carrev.2025.05.031. Epub 2025 May 30. Cardiovasc Revasc Med. 2025. PMID: 40541479
Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
Bharadwaj AS, Abu-Much A, Maini AS, Zhou Z, Li Y, Batchelor WB, Grines CL, Baron SJ, Redfors B, Lansky AJ, Basir MB, O'Neill WW. Bharadwaj AS, et al. Circ Cardiovasc Interv. 2024 Jul;17(7):e013503. doi: 10.1161/CIRCINTERVENTIONS.123.013503. Epub 2024 May 6. Circ Cardiovasc Interv. 2024. PMID: 38708609 Free PMC article. Clinical Trial.